65,437 trials
Medication Adherence · Smoking Cessation
Primary: Acceptability of Intervention Measure (AIM) — 15.76 Mean acceptability score at 12 weeks
Opioid-use Disorder
Primary: Adherence to Medication Assisted Treatment (MAT) — 32; 17 Participants
Healthy Volunteers
Primary: Pharmacokinetics: AUC0-tau — 94.927; 107.30; 294.48; 1059.5 h*ng/mL
Surgical Site Infection
Primary: Participants With Superficial and Deep/Organ Space MRSA Infections Within 90 Days — 70; 25 participants — p=0.13
Recurrent Prostate Cancer
Primary: Changes in Fatigue — 52.4; 53.4 T-score — p=0.454
Mild Cognitive Impairment · Herpes Simplex 1 · Herpes Simplex 2
Primary: Change in Standardized Uptake Value Ratio (SUVR) of (18F-Florbetapir PET) From Week 0 to Week 52. — 0.07; 0.08 Standardized Uptake Value Ratio
Pain, Postoperative · Burns
Primary: A Measurement of Post Operative Pain Involving Skin Graft Donor Site Using Visual Analog Scale (VAS) Ranging 0-10, at 8 Hours Post-operatively — 3.14; 3.68; 3.67 score…
Older Adults · Anxiety · Depression
Primary: PHQ-ADS — 18.35; 16.67; 17.51; 10.95 points
Supracondylar Humerus Fracture
Primary: Subject Reported Pain Level Using the Wong-Baker Faces Pain Scale. — 4.10; 4.46; 3.82; 3.4 units on a scale
Hemorrhoids Third Degree
Primary: Hemorrhoidal Disease Symptom Score — 1; 7 units on a scale
Behavior, Health · Flu · Flu Vaccination
Primary: Proportion of Patients Who Receive the Flu Vaccine at the Visit — 689; 2217; 645; 628 Participants
Pancreas Cancer
Primary: Disease Control Rate (DCR) — 0 DCR, % of participants with CR/PR/SD
Depression · Anxiety · Physical Disability
Primary: Acceptability — 167; 132; 80; 82 Participants
Hiv · HIV Infections · AIDS
Primary: Prevalence of HIV Infection — 6 Participants
Healthy
Primary: Area Under the Concentration-time Curve of Midazolam in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) — 70; 63 hours*nanomole/Liter…